Price to Book Value Chart

View Price to Book Value for CVRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
August 21, 2026 3.792
August 20, 2026 3.792
August 19, 2026 3.765
August 18, 2026 3.672
August 17, 2026 3.672
August 14, 2026 4.112
August 13, 2026 3.926
August 12, 2026 3.645
August 11, 2026 3.472
August 10, 2026 3.164
August 07, 2026 3.191
August 06, 2026 7.931
August 05, 2026 7.450
August 04, 2026 7.330
August 03, 2026 7.344
July 31, 2026 6.910
July 30, 2026 7.184
July 29, 2026 6.609
July 28, 2026 6.609
July 27, 2026 6.516
July 24, 2026 6.329
July 23, 2026 6.529
July 22, 2026 6.796
July 21, 2026 6.636
July 20, 2026 6.369
Date Value
July 17, 2026 6.556
July 16, 2026 7.197
July 15, 2026 7.037
July 14, 2026 6.890
July 13, 2026 7.250
July 10, 2026 7.250
July 09, 2026 6.943
July 08, 2026 7.037
July 07, 2026 7.664
July 06, 2026 7.517
July 02, 2026 7.477
July 01, 2026 7.344
June 30, 2026 6.863
June 29, 2026 5.393
June 26, 2026 5.320
June 25, 2026 4.767
June 24, 2026 4.680
June 23, 2026 4.676
June 22, 2026 4.412
June 18, 2026 4.494
June 17, 2026 4.385
June 16, 2026 4.422
June 15, 2026 4.522
June 12, 2026 4.567
June 11, 2026 4.440

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
NeuroPace, Inc. 40.36
Accuray, Inc. 0.7905
Orthofix Medical, Inc. 0.9291
ResMed, Inc. 5.092
Rockwell Medical, Inc. 0.8983

Price to Book Value Related Metrics

PS Ratio 1.359
Price 3.16
Earnings Yield -62.48%
Market Cap 84.19M